Bill Robertson is the CEO of VaLogic Bio, a leading life sciences compliance firm that has supported over 500 companies—from innovative startups to Fortune 500 organizations—over the past 25+ years. Under Bill’s leadership, VaLogic Bio provides end-to-end solutions in facility design, qualification, and regulatory compliance, helping clients meet the highest standards of quality and safety. Bill brings deep expertise in U.S. FDA and EMA regulations, with a strong focus on sterile product manufacturing. He has guided numerous clients through complex regulatory challenges, including responses to FDA 483s, Warning Letters, and drug shortage mitigation strategies. His work spans cell and gene therapy, Biologics, Pharmaceuticals, Diagnostics, and Medical Devices. Specializing in ICQ, GxP, and CAPA, Bill is driven by a mission to empower biotech companies to achieve regulatory excellence and long-term market success.